Study Title
68Ga-AAZTA-093 PET/CT: First-in-human Study in Patients With Prostate Cancer
Study Details
Description:
68Ga-AAZTA-093 is a novel radiotracer targeting prostate-specific membrane antigen (PSMA). In this study, we observed the safety, biodistribution, radiation dosimetry and diagnostic value of 68Ga-AAZTA-093 PET/CT in patients with prostate cancer.
Sponsor:
First Affiliated Hospital of Fujian Medical University
Government Study Link:
NCT06437496 - Click here to see study onClinicalTrials.gov